| Literature DB >> 34012711 |
Liron Pantanowitz1, Sarah Harrington2.
Abstract
INTRODUCTION: Hologic is developing a digital cytology platform. An educational website was launched for users to review these digitized Pap test cases. The aim of this study was to analyze data captured from this website.Entities:
Keywords: Artificial intelligence; Pap test; cytology; digital pathology; education; whole slide imaging
Year: 2021 PMID: 34012711 PMCID: PMC8112346 DOI: 10.4103/jpi.jpi_96_20
Source DB: PubMed Journal: J Pathol Inform
Figure 1Screenshot from the education website showing the (left) gallery comprised of 24 image objects of interest and corresponding (right) entire ThinPrep cell spot (i.e., interactive whole slide image)
Figure 2Screenshot from the education website showing (left) the bottom right cell in the gallery selected by the user being displayed (right) in much higher magnification within the context of the entire slide. This Pap test was a study case with herpes infection
Figure 3Screenshot from the education website showing the review form that reviewers were asked to complete online
Figure 4Screenshot from the education website showing feedback to the user. In this example the correct interpretation for the study case was negative for intraepithelial lesion or malignancy with associated trichomoniasis and herpes infection
Figure 5Cumulative percent of time (s) spent for online diagnostic assessment of digital Pap tests
Diagnostic summary of study cases
| Reviewer diagnoses (%) | Reference diagnoses (%) | |
|---|---|---|
| Unsatisfactory | 0.1 | 0.0 |
| NILM | 38.9 | 41.1 |
| ASC-US | 3.5 | 1.0 |
| LSIL | 22.3 | 22.3 |
| ASC-H | 2.1 | 0.2 |
| HSIL | 23.1 | 25.5 |
| AGC | 1.6 | 0.7 |
| AIS | 1.5 | 1.5 |
| Adenocarcinoma | 3.5 | 4.0 |
| Squamous cell carcinoma | 3.3 | 3.7 |
| Carcinoma, other | 0.1 | 0.0 |
NILM: Negative for intraepithelial lesion or malignancy, ASC-US: Atypical squamous cells of undetermined significance, LSIL: Low-grade squamous intraepithelial lesion, ASC-H: Atypical squamous cells cannot exclude high grade, AGC: Atypical glandular cells, AIS: Adenocarcinoma in situ, HSIL: High-grade squamous intraepithelial lesion
Cytotechnologist contingency table for diagnostic assessment
| Cytotechnologist reviewer diagnosis | Row total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unsatisfactory | NILM | ASC-US | LSIL | ASC-H | HSIL | AGC | AIS | Adenocarcinoma | SCC | Carcinoma other | ||
| Reference diagnosis | ||||||||||||
| NILM | 11 | 15,779 | 717 | 197 | 116 | 197 | 134 | 26 | 28 | 12 | 1 | 17,218 |
| ASC-US | 0 | 163 | 122 | 115 | 5 | 8 | 0 | 0 | 0 | 0 | 0 | 413 |
| LSIL | 1 | 87 | 362 | 8542 | 31 | 235 | 5 | 4 | 2 | 6 | 1 | 9276 |
| ASC-H | 0 | 6 | 10 | 3 | 20 | 48 | 2 | 0 | 0 | 1 | 0 | 90 |
| HSIL | 0 | 216 | 169 | 424 | 681 | 8574 | 139 | 87 | 108 | 254 | 3 | 10,655 |
| AGC | 1 | 40 | 5 | 3 | 22 | 86 | 65 | 12 | 66 | 7 | 2 | 309 |
| AIS | 9 | 76 | 3 | 4 | 1 | 48 | 125 | 315 | 58 | 7 | 0 | 646 |
| Adenocarcinoma | 6 | 50 | 2 | 2 | 10 | 131 | 169 | 119 | 1122 | 45 | 10 | 1666 |
| SCC | 6 | 10 | 6 | 3 | 9 | 302 | 34 | 39 | 128 | 992 | 7 | 1536 |
| Column total | 34 | 16,427 | 1396 | 9293 | 895 | 9629 | 673 | 602 | 1512 | 1324 | 24 | 41,809 |
The cells shaded in grey indicate an exact diagnostic match. NILM: Negative for intraepithelial lesion or malignancy, ASC-US: Atypical squamous cells of undetermined significance, LSIL: Low-grade squamous intraepithelial lesion, ASC-H: Atypical squamous cells cannot exclude high grade, AGC: Atypical glandular cells, AIS: Adenocarcinoma in situ, HSIL: High-grade squamous intraepithelial lesion, SCC: Squamous cell carcinoma
Pathologist contingency table for diagnostic assessment
| Pathologist diagnosis (hologic) | Row total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unsatisfactory | NILM | ASC-US | LSIL | ASC-H | HSIL | AGC | AIS | Adenocarcinoma | SCC | Carcinoma other | ||
| Confirmed diagnosis | ||||||||||||
| NILM | 3 | 2780 | 198 | 102 | 34 | 90 | 31 | 14 | 5 | 7 | 0 | 3,264 |
| ASC-US | 0 | 34 | 13 | 22 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 73 |
| LSIL | 1 | 65 | 70 | 1567 | 24 | 51 | 1 | 5 | 1 | 12 | 0 | 1,797 |
| ASC-H | 0 | 5 | 4 | 0 | 6 | 9 | 0 | 0 | 0 | 1 | 0 | 25 |
| HSIL | 0 | 62 | 42 | 96 | 78 | 1586 | 40 | 27 | 26 | 74 | 0 | 2,031 |
| AGC | 0 | 11 | 1 | 2 | 3 | 17 | 15 | 0 | 11 | 1 | 0 | 61 |
| AIS | 1 | 8 | 0 | 2 | 1 | 22 | 20 | 53 | 8 | 6 | 0 | 121 |
| Adenocarcinoma | 1 | 13 | 2 | 2 | 4 | 39 | 27 | 26 | 171 | 24 | 2 | 311 |
| SCC | 2 | 3 | 0 | 0 | 1 | 83 | 3 | 6 | 18 | 172 | 2 | 290 |
| Column total | 8 | 2,981 | 330 | 1,793 | 152 | 1,900 | 137 | 131 | 240 | 297 | 4 | 7,973 |
The cells shaded in grey indicate an exact diagnostic match. NILM: Negative for intraepithelial lesion or malignancy, ASC-US: Atypical squamous cells of undetermined significance, LSIL: Low-grade squamous intraepithelial lesion, ASC-H: Atypical squamous cells cannot exclude high grade, AGC: Atypical glandular cells, AIS: Adenocarcinoma in situ, HSIL: High-grade squamous intraepithelial lesion, SCC: Squamous cell carcinoma
Comparison of diagnostic matches for cytotechnologists and pathologists by diagnostic category
| Diagnosis | Diagnostic category match | Higher proportion | |||
|---|---|---|---|---|---|
| Cytotechnologist (%) | Pathologist (%) | ||||
| NILM | 91.6 | 85.2 | Cytotechnologist | 135.052 | <0.001 |
| ASC-US/LSIL | 94.3 | 89.4 | Cytotechnologist | 63.163 | <0.001 |
| ASC-H/HSIL/AGC/AIS/Ca | 92.9 | 90.9 | Cytotechnologist | 13.655 | <0.001 |
| Total | 92.7 | 88.2 | Cytotechnologist | 184.644 | <0.001 |
NILM: Negative for intraepithelial lesion or malignancy, ASC-US: Atypical squamous cells of undetermined significance, LSIL: Low-grade squamous intraepithelial lesion, ASC-H: Atypical squamous cells cannot exclude high grade, HSIL: High-grade squamous intraepithelial lesion, AGC: Atypical glandular cells, AIS: Adenocarcinoma in situ, Ca: Carcinoma
Comparison of diagnostic matches for cytotechnologists and pathologists
| Diagnosis | Exact diagnosis match | Higher proportion | |||
|---|---|---|---|---|---|
| Cytotechnologist (%) | Pathologist (%) | ||||
| NILM | 91.6 | 85.2 | Cytotechnologist | 135.052 | <0.001 |
| ASC-US | 29.5 | 17.8 | Cytotechnologist | 4.256 | 0.039 |
| LSIL | 92.1 | 87.2 | Cytotechnologist | 45.220 | <0.001 |
| ASC-H | 22.2 | 24.0 | Pathologist | 0.035 | 0.851 |
| HSIL | 80.5 | 78.1 | Cytotechnologist | 6.057 | 0.014 |
| AGC | 21.0 | 24.6 | Pathologist | 0.380 | 0.538 |
| AIS | 48.8 | 43.8 | Cytotechnologist | 1.004 | 0.316 |
| Adenocarcinoma | 67.3 | 55.0 | Cytotechnologist | 17.703 | <0.001 |
| Squamous cell carcinoma | 64.6 | 59.3 | Cytotechnologist | 2.935 | 0.087 |
| Total | 85.0 | 79.8 | Cytotechnologist | 135.599 | <0.001 |
NILM: Negative for intraepithelial lesion or malignancy, ASC-US: Atypical squamous cells of undetermined significance, LSIL: Low-grade squamous intraepithelial lesion, ASC-H: Atypical squamous cells cannot exclude high grade, HSIL: High-grade squamous intraepithelial lesion, AGC: Atypical glandular cells, AIS: Adenocarcinoma in situ